{"version":"1.0","type":"rich","width":"560px","height":"140px","title":"Efficacy and safety of Isa-KRd induction before  response-adapted consolidation in transplant eligible newly diagnosed multiple myeloma: an interim analysis of the  IFM2020-02 MIDAS study.","url":"https:\/\/www.myelomasociety.org\/efficacy-and-safety-of-isa-krd-induction-before-response-adapted-consolidation-in-transplant-eligible-newly-diagnosed-multiple-myeloma-an-interim-analysis-of-the-ifm2020-02-midas-study\/","author_name":"IMSound","author_url":"https:\/\/www.myelomasociety.org","thumbnail_url":"https:\/\/www.myelomasociety.org\/wp-content\/uploads\/2024\/07\/IMSound-Logo-only-v2.png","html":"<iframe width=\"560px\" height=\"140px\" src=\"https:\/\/www.myelomasociety.org\/efficacy-and-safety-of-isa-krd-induction-before-response-adapted-consolidation-in-transplant-eligible-newly-diagnosed-multiple-myeloma-an-interim-analysis-of-the-ifm2020-02-midas-study\/?standalonePlayer\"><\/iframe>"}